Abstract
Long-term bone marrow cultures from ten acute myeloid leukemia (AML) patients exposed to recombinant human (rhu) interleukin (IL) 4 from culture initiation failed to develop adherent layers at 5 weeks as compared to controls. The adherent layers from two of our patients expressed IL-1β transcripts constitutively, and all produced IL-6 and leukemia inhibitory factor (LIF) proteins. Our results demonstrate that rhulL-4 markedly inhibited AML-derived adherent layer formation in a time- and dose-dependent manner, and this effect was not mediated through enhanced apoptosis and did not correlate with IL-1β, IL-6 or LIF production.
Original language | English (US) |
---|---|
Pages (from-to) | 519-527 |
Number of pages | 9 |
Journal | Leukemia Research |
Volume | 21 |
Issue number | 6 |
DOIs | |
State | Published - Jun 1997 |
Keywords
- Acute myelogenous leukemia
- Adherent layers
- Cytokine
- Interleukin
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research